Akebia to Host Conference Call
CAMBRIDGE, Mass., March 2,
2023 /PRNewswire/ -- Akebia Therapeutics,
Inc. (Nasdaq: AKBA), a biopharmaceutical company with the
purpose to better the lives of people impacted by kidney disease,
today announced plans to release its financial results for the
fourth quarter and full-year ended December
30, 2022 on Thursday, March 9
prior to the open of financial markets.
Akebia will host a conference call on Thursday, March 9 at 8:30
a.m. ET to discuss its financial results and recent business
highlights. To access the call by phone, please click on this
Registration Link and you will be provided with dial in
details. To avoid delays, we encourage dialing into the conference
call fifteen minutes ahead of the scheduled start time.
A live webcast of the conference call will be available via the
Investors section of Akebia's website at: https://ir.akebia.com/.
An online archive of the webcast can be accessed via the Investors
section of Akebia's website at http://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics,
Inc. is a fully integrated biopharmaceutical company with the
purpose to better the lives of people impacted by kidney
disease. Akebia was founded in 2007 and is
headquartered in Cambridge,
Massachusetts. For more information, please visit our
website at www.akebia.com,
which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes
Carrasco
mcarrasco@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-fourth-quarter-and-full-year-2022-financial-results-and-discuss-recent-business-highlights-301759965.html
SOURCE Akebia Therapeutics